NCT04394416View on ClinicalTrials.gov

Trial of Imatinib for Hospitalized Adults With COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 2, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

July 17, 2025

Conditions
COVID-19
Interventions
DRUG

Imatinib

Therapeutic

DRUG

Placebo oral tablet

Placebo

Trial Locations (1)

21201

University of Maryland Medical Center, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT04394416 - Trial of Imatinib for Hospitalized Adults With COVID-19 | Biotech Hunter | Biotech Hunter